Management of Acute Kidney Injury in the Intensive Care Unit: A Cost-effectiveness Analysis of Daily vs Alternate-Day Hemodialysis | Acute Kidney Injury | JAMA Internal Medicine | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.204.186.91. Please contact the publisher to request reinstatement.
1.
Waikar  SSCurhan  GCWald  R  et al.  Declining mortality in patients with acute renal failure, 1988 to 2002.  J Am Soc Nephrol 2006;17 (4) 1143- 1150PubMedGoogle ScholarCrossref
2.
Ali  TKhan  ISimpson  W  et al.  Incidence and outcomes in acute kidney injury: a comprehensive population based study.  J Am Soc Nephrol 2007;18 (4) 1292- 1298PubMedGoogle ScholarCrossref
3.
Ronco  CBellomo  RHomel  P  et al.  Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomized trial.  Lancet 2000;356 (9223) 26- 30PubMedGoogle ScholarCrossref
4.
Schiffl  HLang  SMFischer  R Daily hemodialysis and the outcome of acute renal failure.  N Engl J Med 2002;346 (5) 305- 310PubMedGoogle ScholarCrossref
5.
Noble  JSSimpson  KAllison  ME Long-term quality of life and hospital mortality in patients treated with intermittent or continuous hemodialysis for acute renal and respiratory failure.  Ren Fail 2006;28 (4) 323- 330PubMedGoogle ScholarCrossref
6.
Manns  BDoig  CJLee  H  et al.  Cost of acute renal failure requiring dialysis in the intensive care unit: clinical and resource implications of renal recovery.  Crit Care Med 2003;31 (2) 449- 455PubMedGoogle ScholarCrossref
7.
Morgera  SKraft  AKSiebert  G  et al.  Long-term outcomes in acute renal failure patients treated with continuous renal replacement therapies.  Am J Kidney Dis 2002;40 (2) 275- 279PubMedGoogle ScholarCrossref
8.
Bagshaw  SMLaupland  KBDoig  CJ  et al.  Prognosis for long-term survival and renal recovery in critically ill patients with severe acute renal failure: a population-based study.  Crit Care 2005;9 (6) R700- R709PubMedGoogle ScholarCrossref
9.
Schiffl  H Renal recovery from acute tubular necrosis requiring renal replacement therapy: a prospective study in critically ill patients.  Nephrol Dial Transplant 2006;21 (5) 1248- 1252PubMedGoogle ScholarCrossref
10.
Korkeila  MRuokonen  ETakala  J Costs of care, long-term prognosis and quality of life in patients requiring renal replacement therapy during intensive care.  Intensive Care Med 2000;26 (12) 1824- 1831PubMedGoogle ScholarCrossref
11.
Abou Ayache  RBridoux  FPessione  F  et al.  Preemptive renal transplantation in adults.  Transplant Proc 2005;37 (6) 2817- 2818PubMedGoogle ScholarCrossref
12.
Coresh  JAstor  BCGreene  T  et al.  Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey.  Am J Kidney Dis 2003;41 (1) 1- 12PubMedGoogle ScholarCrossref
13.
US Renal Data System, USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States.  Bethesda, MD National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases2006;
14.
 2005 Annual Report of the US Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients.  US Organ Procurement and Transplantation Network and Scientific Registry of Transplant Recipients Web site. http://www.optn.org/AR2005/default.htm. Accessed October 15, 2006Google Scholar
15.
Miller  RD Risks Related to Surgery: Miller's Anesthesia. 6th ed. New York, NY Elsevier Churchill Livingstone2005;914- 915
16.
Gorodetskaya  IZenios  SMcCulloch  CE  et al.  Health-related quality of life and estimates of utility in chronic kidney disease.  Kidney Int 2005;68 (6) 2801- 2808PubMedGoogle ScholarCrossref
17.
Maor  YKing  MOlmer  L  et al.  A comparison of three measures: the time trade-off technique, global health-related quality of life and the SF-36 in dialysis patients.  J Clin Epidemiol 2001;54 (6) 565- 570PubMedGoogle ScholarCrossref
18.
Arnesen  TTrommald  M Roughly right or precisely wrong? systematic review of quality-of-life weights elicited with the time trade-off method.  J Health Serv Res Policy 2004;9 (1) 43- 50PubMedGoogle ScholarCrossref
19.
Matas  AJSchnitzler  M Payment for living donor (vendor) kidneys: a cost-effectiveness analysis.  Am J Transplant 2004;4 (2) 216- 221PubMedGoogle ScholarCrossref
20.
Golan  YWolf  MPPauker  SG  et al.  Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis.  Ann Intern Med 2005;143 (12) 857- 869PubMedGoogle ScholarCrossref
21.
Burchardi  HSchneider  H Economic aspects of severe sepsis: a review of intensive care unit costs, cost of illness, and cost effectiveness of therapy.  Pharmacoeconomics 2004;22 (12) 793- 813PubMedGoogle ScholarCrossref
22.
 Archived Consumer Price Index News Releases.  Bureau of Labor Statistics Web site. http://www.bls.gov/cpi/home.htm#data. Accessed October 5, 2006Google Scholar
23.
Go  ASChertow  GMFan  D  et al.  Chronic kidney disease and the risk of death, cardiovascular events, and hospitalization.  N Engl J Med 2004;351 (13) 1296- 1305PubMedGoogle ScholarCrossref
24.
Hamel  MBPhillips  RSDavis  RB  et al. SUPPORT Investigators, Outcomes and cost-effectiveness of initiating dialysis and continuing aggressive care in seriously ill hospitalized adults: Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments (SUPPORT).  Ann Intern Med 1997;127 (3) 195- 202PubMedGoogle ScholarCrossref
25.
Bonventre  JV Daily hemodialysis: will treatment each day improve the outcome in patients with acute renal failure?  N Engl J Med 2002;346 (5) 362- 364PubMedGoogle ScholarCrossref
26.
Bagshaw  SM The long-term outcome after acute renal failure.  Curr Opin Crit Care 2006;12 (6) 561- 566PubMedGoogle ScholarCrossref
27.
Palevsky  PMO’Connor  TZhang  JHStar  RASmith  MW Design of the VA/NIH Acute Renal Failure Trial Network (ATN) Study: intensive versus conventional renal support in acute renal failure.  Clin Trials 2005;2 (5) 423- 435PubMedGoogle ScholarCrossref
Original Investigation
September 8, 2008

Management of Acute Kidney Injury in the Intensive Care Unit: A Cost-effectiveness Analysis of Daily vs Alternate-Day Hemodialysis

Author Affiliations

Author Affiliations: Division of Nephrology (Drs Desai and Chertow), Center for Health Policy and Primary Care and Outcomes Research (Drs Desai, Garber, and Owens), School of Medicine (Ms Baras and Dr Berk), and Graduate School of Business (Ms Nakajima), Stanford University, Stanford, California; and Department of Medicine, Veterans Affairs Palo Alto Health Care System, Palo Alto, California (Drs Garber and Owens).

Arch Intern Med. 2008;168(16):1761-1767. doi:10.1001/archinte.168.16.1761
Abstract

Background  Although evidence suggests that a higher hemodialysis dose and/or frequency may be associated with improved outcomes, the cost-effectiveness of a daily hemodialysis strategy for critically ill patients with acute kidney injury (AKI) is unknown.

Methods  We developed a Markov model of the cost, quality of life, survival, and incremental cost-effectiveness of daily hemodialysis, compared with alternate-day hemodialysis, for patients with AKI in the intensive care unit (ICU). We employed a societal perspective with a lifetime analytic time horizon. We modeled the efficacy of daily hemodialysis as a reduction in the relative risk of death on the basis of data reported in the 2004 clinical trial published by Schiffl et al. We performed 1- and 2-way sensitivity analyses across cost, efficacy, and utility input variables. The main outcome measure was cost per quality-adjusted life-year (QALY).

Results  In the base case for a 60-year-old man, daily hemodialysis was projected to add 2.14 QALYs and $10 924 in cost. We found that the cost-effectiveness of daily hemodialysis compared with alternate-day hemodialysis was $5084 per QALY gained. The incremental cost-effectiveness ratio became less favorable (>$50 000 per QALY gained) when the maintenance hemodialysis rate of the daily hemodialysis group was varied to more than 27% and when the difference in 14-day postdischarge mortality between the alternatives was varied to less than 0.5%.

Conclusion  Daily hemodialysis is a cost-effective strategy compared with alternate-day hemodialysis for patients with severe AKI in the ICU.

×